SPONSORED

Maine cannabis stores are gearing up for the crowds

The first legal cannabis shops in the US state are expecting large numbers of visitors.

•• 4 Min
Maine cannabis stores are gearing up for the crowds

Thomas Winstanley recalls the long lines at marijuana shops opening in Massachusetts just before Thanksgiving 2018. He would have expected the same when his company's South Portland store opened on Friday, but the coronavirus is adding a twist this year Theory Wellness opens on its first day of sales as one of only eight adult retail stores licensed to operate in Maine. The company has a wealth of experience. It is based in Massachusetts, where it has two stores and is about to get its third medical marijuana business approved. "I think one of the lessons we're taking from opening recreational facilities in Massachusetts is that you never really know what to expect," said Winstanley, director of marketing for Theory Wellness. Shopkeepers expect interest pent up when Maine stores open nearly four years after voter legalization of recreational marijuana. The market could start slowly in anticipation of product shortages when companies get the license and begin expanding. In the course of the market opening, eight cultivation plants, four manufacturing plants and a test laboratory were licensed by the state for recreational activities. Theory Wellness encourages customers to pre-book online and schedule appointments for their purchases to be picked up, a policy many Massachusetts stores have put in place to reduce waiting times. Customers can still go inside. Winstanley said pre-orders have been very popular in Massachusetts, where unlike Maine, recreational and medical stores can operate under the same roof. People looking to experience the first day of sales in Maine will have to be patient as they will be asked to maintain a social distance of six feet and be given a card proving they will be 21 when they walk in and out of the store stand at the cash register, he said. Theory Wellness will only accept cash or PIN-based debit cards that have a $ 2.75 ATM transaction fee. The Maine tax on cannabis sales is 10 percent. Payment methods will vary across state. The pandemic has delayed the opening of the Maine market. In September, when the first active licenses were issued, Erik Gundersen, director of the Maine Office of Marijuana Policy, said he expected the market to develop in the coming weeks and months, although initially it was both in accessibility to consumers and product availability will be limited. John Lorenz owns Sweet Relief on Route 1 in Northport, one of the first adult marijuana retail stores in the state to be approved. Credit: Abigail Curtis | BDN John Lorenz, owner of Sweet Relief in Northport, said he expected queues of people to camp outside the stores overnight on Thursday, much like customers line up outside Apple stores the night before a new iPhone is released. He is not worried about the product shortages that some other states have experienced when opening up leisure markets. "It will take time, as will next summer's season and harvest, to bring the program to its full potential," he said. Other players in the industry, such as licensed chocolatiers, bakers, and extractors, also need to increase the production of edibles, which are expected to be very scarce for recreational stores initially. Lorenz said he is making an effort to get products for sale and expects many stores in Maine to be selling mostly buds in October. Customers who are 21 years of age or older are permitted to purchase and own up to 2.5 ounces of marijuana, marijuana concentrate, and marijuana products, including no more than 5 grams of marijuana concentrate, according to the Maine Office of Marijuana Policy. However, some stores may set their own limits that are lower, said bureau of marijuana policy spokesman David Heidrich. Another adult store in South Portland, Seaweed, has related businesses with licenses to grow and manufacture so it and Theory Wellness will be the only two vertically integrated recreational marijuana companies in Maine when the market begins. Theory Wellness, one of the first licensed recreational marijuana stores in Maine, on Tuesday, September 8, 2020. State officials announced that the South Portland store, along with Sweet Relief in Northport, would be the first to be licensed as of October 9, 2020 received the sale of cannibis. Credit: Robert F. Bukaty / AP Theory Wellness also has active licenses to grow and manufacture in Waterville. Until production is ramped up, Theory Wellness will purchase plants from licensed medical marijuana caregivers and put them through a healing process to prepare the products for sale, Winstanley said. Winstanley said Theory Wellness has started planting seedlings at the Waterville facility and will have its own plants in about two to three months. "We're working very hard to be able to produce," he said. "At the same time, I think if we have learned anything in the cannabis industry, it is that there are no guarantees that everything will go according to plan. We will take it every day."

USARetailCannabis

Most Popular News

  1. SpaceX’s $8B Spectrum Deal Sends AT&T, Verizon, and T-Mobile Plummeting
  2. Is Project Vault Securing America’s Supply Chain or Squeezing It to the Breaking Point?
  3. Why Gautam Lohia Shifted from Global Consulting to Reboot a $20M Tech Micro-Cap
  4. Everyday Luxury, Unstoppable Scale: Aritzia Delivers 44% Net Revenue Growth
  5. Can Navy SEAL Leadership and Big Tech Scale Revolutionize Airborne Threat Detection?

Disclaimer


This report should not be viewed as investment advice or as an offer to buy or sell any securities or as an invitation or solicitation of an offer to buy or sell any securities. Neither the author of this report, its publisher, nor any other person associated with the publication of this report, are registered brokers, investment dealers, investment advisers, or financial advisers. The information in this report has not been tailored to the particular needs or circumstances of readers and should not be relied upon as investment advice or recommendations to purchase or sell any of the securities presented in this report. Readers seeking investment advice should contact qualified and registered brokers, investment dealers, investment advisers, or financial advisers prior to making any decision to buy or sell any of the securities referred to in this report. The information in this report should not be construed as investment, legal, or tax advice. No recommendation is made as to whether an investment in the presented securities is suitable for any reader in light of the reader’s particular circumstances.

Readers are cautioned that the publisher of this report covers exclusively securities that carry a high degree of volatility. Investing in such securities is highly speculative and carries a high degree of risk. Investors in such securities could lose all or a substantial portion of their investment. Only those investors who can afford to lose all or a substantial portion of their investment should consider investing in the securities referred to in this report.

This report may include information obtained from publicly available sources, including third-party reports or analysis. Neither the author nor publisher of this report, nor www.juniorstocks.com or its owners, have undertaken any independent investigation into the factual information used in this report, and the information in this report is provided without any warranty of any kind. No representations or warranties are provided regarding the accuracy or completeness of the information provided in this report. Statements of opinion or belief are those of the authors and/or publisher of this report. These statements of opinion or belief are expressions of the author’s and/or publisher’s judgment, and there is no guarantee that those judgments will turn out to be correct. No inference should be drawn that the author and/or publisher have any special or greater knowledge about the presented companies or their securities, or any particular expertise in the industries or markets in which the company operates. Readers should conduct their own due diligence and seek professional advice prior to investing in any securities presented on Juniorstocks.com.

Certain statements in this report constitute “forward-looking” statements. Forward-looking statements often, but not always, are identified by the use of words such as “seek,” “anticipate,” “believe,” “plan,” “estimate,” “expect,” “targeting,” and “intend” and statements that an event or result “may,” “will,” “should,” “could,” or “might” occur or be achieved and other similar expressions. Forward-looking statements express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance; they are not statements of historical facts and should not be viewed as any guarantee of any future result. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. The author and/or publisher of this report disclaims any obligation to update the forward-looking statements in this report, whether as a result of new information, future events, or results or otherwise. There is no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.

The information provided in this report is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to applicable law or regulation, or would subject the author or publisher of this report to any registration requirement in such jurisdiction or country.

Information about the editor of this publication:
Juniorstocks.com is a service provided by Piccadilly Capital Group, Office 66, 101 Clapham High Street, London, SW4 7TB, UK. Piccadilly Capital Group is not the publisher of this report and was not paid for the publication of this report. Piccadilly Capital Group seeks to generate web traffic and a growing number of followers through the publication of articles or reports. Directors, officers, and other insiders of the publisher own an interest in Piccadilly Capital Group. Piccadilly Capital Group does not endorse or recommend the business, products, services, or securities of any company mentioned on www.juniorstocks.com. Piccadilly Capital Group will not share your information with any outside third parties. Due to the new data protection basic regulation, we ask you to read our data protection declaration carefully.

Note on copyright:
The contents published on this website and on connected media (e.g., e-mail, X, Facebook) are subject to applicable copyright and ancillary copyright laws. Any use not permitted by applicable copyright and ancillary copyright laws requires the prior written consent of the provider or the respective rights holder. In particular, this applies to the duplication, editing, translation, storage, processing, or reproduction of content in databases or other electronic media and systems. Contents and rights of third parties are marked as such. Unauthorized reproduction or transmission of individual contents or complete pages is not permitted and is punishable by law. Only the production of copies and downloads for personal, private, and non-commercial use is permitted. Links to the provider's website are always welcome and do not require the consent of the provider of the website. Photos and images on the website may not be shared unless the publisher itself has acquired the initial rights from authorized sources. The presentation of this website in external frames is only allowed with written permission. If you notice any violations, please inform us. Please note: The content of our articles, emails, or other publications or social networks such as X, LinkedIn or Facebook is exclusively intended for the designated addressee(s). If you are not the addressee of these articles, emails, or other publications in the market letter or social networks such as Twitter or Facebook or his or her legal representative, please note that any form of publication, reproduction, or distribution of the content of these articles, emails, or other publications in the market letter or social networks such as X, LinkedIn or Facebook is prohibited. Falsifications of the original content of this message during data transmission cannot be excluded in principle.